Imel Biotherapeutics, Inc. reported raising $15 Million in an initial SEC Form D filing, from an offering of $20 Million
PRIVATENov 15, 2021$15M of $20M raised Amount Raised
$15 Million
$15 Million sold, per SEC Form D (first sale Nov 15, 2021)
WalthamHealthcareWho to call at Imel Biotherapeutics, Inc., and when
A new round usually means Imel Biotherapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Imel Biotherapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Imel Biotherapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Imel Biotherapeutics, Inc.. With Fundz connected, it knows.
Watch Fundz in Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★ 4.8/5 on G2
Company
Imel Biotherapeutics, Inc.
Location
303 WYMAN STREET, SUITE 300
Waltham, Massachusetts, United States
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Imel Biotherapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Imel Biotherapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.
